Concerns about the safety and efficacy of mRNA COVID-19 shots have increased after a January 3 report that drug maker Moderna failed to inform the U.S. government of the death of a child during ...

Paxlovid’s role in treating COVID-19 is not ending — it is evolving, according to the results of two national trials ...

RALEIGH (WTVD) -- COVID-19 vaccine testing is well underway but there's concern that we won't know exactly how well they work in the communities that need them most. Companies conducting the trials ...

The Food and Drug Administration will issue guidelines requiring clinical trials prior to the approval of new COVID-19 boosters, a spokesperson confirmed to The Daily Signal. The FDA’s new framework ...

CHICAGO (WLS) -- As the COVID-19 pandemic spreads, hospitals around the world have begun testing convalescent plasma as a potential treatment. The University of Chicago Medicine is one facility who is ...

Invivyd, Inc. announced the publication of results from its CANOPY Phase 3 clinical trial of pemivibart, a monoclonal antibody aimed at preventing symptomatic COVID-19. This trial, unique for its ...

Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A drug that Wednesday received worldwide attention for potential in treating coronavirus patients will be tested at Kettering Medical Center, the hospital announced today. >> Coronavirus: Complete ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct ...

The Trump administration on Tuesday eliminated 22 mRNA vaccine development projects for COVID-19 and bird flu, a stark shift away from technology credited with bringing the United States out of the ...